by Garth Sundem | Mar 6, 2019 | Featured, Honors, Latest News
James DeGregori, PhD The American Association for Cancer Research (AACR) announced today that in partnership with the Lung Cancer Initiative at Johnson & Johnson, it will fund a major grant led by University of Colorado Cancer Center investigators to pinpoint the...
by Garth Sundem | Feb 11, 2019 | Latest News, Research
Alison Bauer, PhD It is well known that exposure to high-molecular weight polycyclic aromatic hydrocarbons (PAHs) increases cancer risk, leading to regulation of compounds like benzo(a)pyrene (BAP). However, less is known about the health effects of low molecular...
by CU Cancer Center | Jan 3, 2019 | C3 Magazine, Featured, Patient Care
At 32 years old and 33 weeks pregnant, Emily Daniels lived the kind of life that many of us strive to achieve. With a baby boy on the way, a loving husband, a healthy and happy 3-year-old daughter, family and friends close by, a good job, and an active social life,...
by Garth Sundem | Dec 31, 2018 | Featured, Latest News, Research
According to the National Cancer Institute, patients diagnosed with non-small cell lung cancer (NSCLC) between the years 1995 and 2001 had 15 percent chance of being alive 5 years later. For patients with stage IV disease, describing cancer that has spread to distant...
by Garth Sundem | Nov 8, 2018 | Featured, Latest News, Research
The HER2 gene is a well-known driver of breast cancer, where changes in this gene are found in about 1-in-5 cases of the disease. HER2 also contributes to about 3 percent of lung cancers, representing about 6,500 patients per year. But while drugs like trastuzumab and...
